THC Biomed Intl Ltd. (THCBF)

Market Cap	164.00
Revenue (ttm)	1.64M -9.9%
Net Income	-2.71M
EPS	-0.02
Shares Out	163.94M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	394
Open	0.0010
Previous Close	0.0010
Day's Range	0.0010 - 0.0245
52-Week Range	0.000001 - 0.0245
Beta	-159.24
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 24, 2026

About THC Biomed Intl

THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under the Always Hi brand name; and transport solution for young live plants under the Cloneshipper brand name. The company was founded in 2012 and is based i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2012
• Employees: 35
• Stock Exchange: OTCMKTS
• Ticker Symbol: THCBF

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 25, 2026

Data Sources Report a data error